In September 2023, Indonesia’s Ministry of Health (MoH) published Circular Letter Number HK.02.02/E/1721/2023 concerning Post-Market Testing of Medical Devices, recommending independent post-market testing to be done by distributor license owners on circulated products, ensuring that products continue to meet safety and quality requirements.
The self-conducted post-market testing should be carried out periodically, at least once every 2 years, conducted by an accredited test laboratory, and reported to the MoH’s Directorate of Medical Device Supervision through their website.
Post-market testing of the medical devices can be done voluntarily by the distributor license owners. Products that have submitted independent post-market test results within qualifications will be rewarded and will receive a priority benefit, considered as top-selection products in the e-Katalog. Those who have passed the post-market Evaluation process will also be listed and published on the Directorate of Medical Device Supervision website.
Medical devices that are a priority for independent post-market testing are listed in the table below:
Medical Device Group |
Product Type |
Testing |
Non-electromedical Sterile |
All product types |
Sterilization test based on FI VI |
Electromedical |
USG |
Electrical Safety Test and Product performance test |
Non-electromedical Sterile |
Condoms |
Test appearance, dimensions, density, explosive power, Leakage |
Non-electromedical Sterile |
Disposable Syringe |
Sterility test |
Syringe sharpness test |
||
Non-electromedical Sterile |
Sterile Gauze |
Sterility test |
Fluorescence Test |
||
IVD |
RDT HIV |
Sensitivity Test, Specificity Test and Post Market Test (Physical and Functional Test) |
*Note: The samples taken are not leftover samples or samples that are in the production facility storage warehouse.
References:
Circular Letter Number HK.02.02/E/1721/2023 concerning Post Market Testing of Medical Devices